Access program for diabetes tech in kids with type 1
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial helps children with type 1 diabetes get advanced diabetes technology, aiming to reduce gaps in access for families with fewer resources. It will check whether these tools are usable and helpful for diabetes care in children who meet the study needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has had type 1 diabetes for at least 1 year and is using insulin (shots or a pump)
- Recent blood sugar testing (HbA1c) is at least 8.0% on two checks in the last year
- Your child should have a higher risk of limited access, such as lower household income (or special circumstances approved by the study team)
- Your child is not using a hybrid “automated insulin delivery” system right now
- Your child does not have severe skin problems that would make wearing device skin/adhesives hard
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a new approach to help people with type 1 diabetes who have high blood sugar (A1c above 8.5%) and are not on an insulin pump. It looks at whether using diabetes technology can improve your glucose control.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
Hear when a new Child trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.